Evidence map›Paper›PMID 30386467›Full record

ArticleWorld journal of hepatology2018

Comparison of hepatitis C virus testing recommendations in high-income countries.

Risha Irvin, Kathleen Ward, Tracy Agee, Noele P Nelson, Claudia Vellozzi, David L Thomas, Alexander J Millman

Abstract read
In one paragraph

Article in World journal of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Risha IrvinDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States. rirvin1@jhmi.edu.
Kathleen WardDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Tracy AgeeDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Noele P NelsonDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.
Claudia VellozziDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.
David L ThomasDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.
Alexander J MillmanDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30329, United States.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

aimTo investigate hepatitis C virus (HCV) testing recommendations from the United States and other high-income countries.

methodsA comprehensive search for current HCV testing recommendations from the top quartile of United Nations Human Development Index (HDI) countries (very high HDI) was performed using Google and reviewed from May 1 - October 30, 2014 and re-reviewed April 1 - October 2, 2017.

resultsOf the 51 countries identified, 16 had HCV testing recommendations from a government body or recommendations issued collaboratively between a government and a medical organization. Of these 16 countries, 15 had HCV testing recommendations that were primarily risk-based and highlight behaviors, exposures, and conditions that are associated with HCV transmission in that region. In addition to risk-based testing, the HCV Guidance Panel (United States) incorporates recommendations for a one-time test for individuals born during 1945-1965 (the birth cohort) without prior ascertainment of risk into their guidance. In addition to the United States, six other countries either have an age-based testing recommendation or recommend one-time testing for all adults independent of risk factors typical of the region.

conclusionThis review affirmed the similarities of the HCV Guidance Panel's guidance with those of recommendations from very high HDI countries.

Indexed as

GuidelinesHepatitis CMass screeningRecommendationsTesting

Identifiers

PMID30386467
PMCPMC6206144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.